0001171843-15-001430.txt : 20150316 0001171843-15-001430.hdr.sgml : 20150316 20150316114959 ACCESSION NUMBER: 0001171843-15-001430 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150304 FILED AS OF DATE: 20150316 DATE AS OF CHANGE: 20150316 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sucampo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001365216 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133929237 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4520 EAST-WEST HIGHWAY, 3RD FLOOR CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019613400 MAIL ADDRESS: STREET 1: 4520 EAST-WEST HIGHWAY, 3RD FLOOR CITY: BETHESDA STATE: MD ZIP: 20814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Donley Matthew Maxwell CENTRAL INDEX KEY: 0001636642 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33609 FILM NUMBER: 15701745 MAIL ADDRESS: STREET 1: 4520 EAST WEST HIGHWAY, 3RD FLOOR CITY: BETHESDA STATE: MD ZIP: 20814 3 1 formthree.xml X0206 3 2015-03-04 0 0001365216 Sucampo Pharmaceuticals, Inc. SCMP 0001636642 Donley Matthew Maxwell 4520 EAST WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 0 1 0 0 Exec. V.P., Human Resources Employee Stock Option (right to buy) 7.40 2024-06-09 Class A Common Stock 150000 D Employee Stock Option (right to buy) 6.75 2018-09-11 2024-09-11 Class A Common Stock 25000 D The option vests in four equal annual installments beginning on June 9, 2015 Performance conditions for accelerated vesting: one third of the total award may vest prior to the vesting date each time the Compensation Committee approves management's recommendation that certain pre-determined targets have been achieved in one of the three categories of strategic objectives of the Company. Exhibit 24 - Power of attorney /s/ Matthew Maxwell Donley 2015-03-16 EX-24 2 exh_24.htm EXHIBIT 24

Exhibit 24

 

POWER OF ATTORNEY

 

(For Executing Form ID and Forms 3, 4 and 5)

 

Know all by these presents that the undersigned hereby constitutes and appoints Charles McFalls, Financial Reporting Manager, or delegate, signing individually, the undersigned’s true and lawful attorneys-in fact and agents to:

 

(1)      Prepare, execute in the undersigned’s name and on the undersigned’s behalf, and submit to the Securities and Exchange Commission a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the Securities and Exchange Commission of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation thereunder;

 

(2)      Prepare, execute in the undersigned’s name and on the undersigned’s behalf, and submit to the Securities and Exchange Commission Forms 3, 4 and 5 (including amendments thereto and joint filing agreements in connection therewith) in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

 

(3)      Do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to prepare and execute any such Form 3, 4 or 5 (including amendments thereto and joint filing agreements in connection therewith) and file such Forms with the Securities and Exchange Commission and any stock exchange, self-regulatory association or any other authority; and

 

(4)      Take any other action of any type whatsoever in connection with the foregoing that, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required of the undersigned, it being understood that the documents executed by the attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as the attorney-in-fact may approve in the attorney-in-fact’s discretion.

 

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, and their substitutes, in serving in such capacity at the request of the undersigned, are not assuming (nor is Sucampo Pharmaceuticals, Inc. assuming) any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

 

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by Sucampo Pharmaceuticals, Inc., unless earlier revoked by the undersigned in a signed writing delivered to Sucampo Pharmaceuticals, Inc. and the attorneys-in fact. This Power of Attorney revokes any other power of attorney that the undersigned has previously granted to representatives of Sucampo Pharmaceuticals, Inc. and agents acting on its behalf.

 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of the date written below.

 

Dated: March 12, 2015 /s/ Matthew Maxwell Donley  
  Matthew Maxwell Donley